BioInvent International is a Swedish biotechnology company based in Lund that discovers and develops antibody-based medicines for cancer. Its work centres on immuno-oncology, creating antibodies designed to activate the body's immune system against tumours. The company advances its own drug candidates through early clinical testing and also works with pharmaceutical partners on antibody programmes. Its customers and collaborators are mainly hospitals, clinical research groups and other drug developers involved in cancer treatment research.
The shares are listed on the London Exchange in UK under the code 0H22, and the price on this page is in Swedish kronor (SEK). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #3279 of 3787 on the London Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendWeak
24/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-13.6%
From 52-week high-37.3%
MomentumWeak
32/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-6.4%
6-month return-4.5%
12-month, skipping last month-18.2%
Stability (higher is calmer)Weak
29/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)51.0%
Worst drawdown, 1 year (smaller is calmer)-39.3%
LiquidityWeak
7/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.00M SEK
Zero-volume days66.7%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 19.46 – 46.96Daily closes, split-adjusted
Signals
50-day average22.95
200-day average24.32
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)9.48
Technical summary
Daily
Strongly bearish
2 bullish · 1 neutral · 13 bearish
Weekly
Strongly bearish
0 bullish · 1 neutral · 11 bearish
Monthly
Strongly bearish
0 bullish · 1 neutral · 7 bearish
Moving averages (daily)
SMA 10
22.25
Bearish
EMA 10
21.85
Bearish
SMA 20
22.59
Bearish
EMA 20
22.29
Bearish
SMA 50
22.95
Bearish
EMA 50
22.79
Bearish
SMA 100
23.39
Bearish
EMA 100
23.38
Bearish
SMA 200
24.32
Bearish
EMA 200
24.73
Bearish
Oscillators (daily)
RSI (14)
39.41
Neutral
MACD (12, 26)
-0.45
Bearish
Momentum (12)
-7.97
Bearish
Stochastic %K (14)
2.44
Bullish
Williams %R (14)
-97.56
Bullish
CCI (20)
103.3
Bearish
Pivot points (classic, last session)
S3
-13.60
S2
3.70
S1
12.35
Pivot
29.66
R1
38.31
R2
55.61
R3
64.26
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in SEK. Educational only, not financial advice.
